Objective: a-Melanocyte-stimulating hormone (a-MSH), b-endorphin and other pro-opiomelanocortin-(POMC) derived peptides have been detected in the heart, but it is uncertain whether they are synthesized by cardiomyocytes or by cardiac nerves innervating the heart. The objective of this study was to determine whether POMC peptides are synthesized by cardiomyocytes. Methods: Pro-opiomelanocortin peptides were localized in rat heart by immunohistochemistry using antisera against a-MSH, b-endorphin and aN-acetyl-b-endorphin, the predominant POMC peptides found in heart. Pro-opiomelanocortin mRNA was investigated by reverse transcription polymerase chain reaction (RT-PCR) using primers that discriminate between full-length POMC mRNA and a 59 truncated POMC transcript that is presumed to be non-functional. Results: a-Melanocyte-stimulating hormone, b-endorphin and aN-acetyl-b-endorphin immunoreactivities were localized in atrial myocytes, particularly in the atrial appendages, but not to a significant extent in ventricular myocytes. Cardiac nerves were not immunostained. Atrial natriuretic peptide (ANP) immunoreactivity was similarly distributed in the adult heart. In neonatal heart, POMC-peptide and ANP immunoreactivities were present in both atrial and ventricular myocytes. RT-PCR amplification showed that full-length POMC mRNA transcripts were present in both atrial and ventricular tissue and provide evidence that 59 truncated POMC mRNA is expressed in heart. Conclusions: These results support the hypothesis that cardiomyocytes synthesize POMC peptides.
Introduction
vestigations have shown that cardiomyocytes also synthesize and secrete met-enkephalin- [5] [6] [7] [8] and dynorphinThe discovery of atrial natriuretic peptide (ANP) more related peptides [8] [9] [10] [11] . than a decade ago led to the realization that atrial carCardiac tissue also contains adrenocorticotropic hordiomyocytes perform a dual role in mammalian heart as mone (ACTH), b-endorphin and related proboth muscle and endocrine cells [1, 2] . Atrial myocytes opiomelanocortin-(POMC) derived peptides, although far store ANP in secretory vesicles and release it by the less is known about their cellular localization or function regulated secretory pathway, much like typical endocrine in the heart [12] [13] [14] [15] [16] [17] . Pro-opiomelanocortin peptides were cells [3, 4] . Ventricular cardiomyocytes also synthesize first identified in heart by Saito et al. [12] who reported ANP, albeit in far lower amounts, but they secrete it by the that ACTH immunoreactivity is present in rat heart extracts. Forman et al. [14] later provided definitive evidence that b-endorphin and its immediate precursor, b-lipotropin, are detectable in cardiac tissue. They also thesize POMC, however, because they failed to discrimireported that the ratio of b-endorphin to b-lipotropin is nate between full-length POMC mRNA and a second, 59 influenced by hemorrhagic shock, cardiac hypertrophy and truncated POMC transcript ( Fig. 1 ) expressed in brain other physiological stimuli, providing evidence that POMC [20] [21] [22] [23] and many peripheral tissues [21, [24] [25] [26] [27] [28] [29] [30] [31] . The 59 processing can be regulated in heart [17] . Our laboratory truncated POMC transcript lacks the POMC signal seextended these findings by showing that ACTH and bquence encoded by exon 2 of the POMC gene and is thus endorphin undergo extensive post-translational processing unlikely to undergo translation [27] [28] [29] . This short POMC in cardiac tissue [16] . ACTH is almost entirely converted transcript is far more abundant than full-length POMC to a-melanocyte-stimulating hormone-(a-MSH) related mRNA in the testes, ovaries, pancreas and other peripheral peptides. Correspondingly, virtually all of the immunotissues that express the POMC gene [26, 30, 31] . However, reactive b-endorphin isolated from heart is attributable to POMC peptide concentrations are correlated with full-N-terminal acetylated and carboxy-terminal truncated blength, not 59 truncated, POMC mRNA levels in these endorphin peptides, rather than b-endorphin , the opioid tissues, consistent with the conclusion that 59 truncated 1 -31 form of the peptide [16] . Heart tissue thus contains a-MSH POMC mRNA is not translated [26] . The oligonucleotides and non-opioid b-endorphin peptides but little ACTH or used in earlier studies to localize POMC mRNA in rat opioid active b-endorphin . heart by in situ hybridization are unable to discriminate 1 -31 Forman and Bagasra [18] were also the first to provide between 59 truncated and full-length POMC mRNAs evidence that POMC may be synthesized by carbecause they hybridize to a sequence common to both diomyocytes. They reported that POMC mRNA is detecttranscripts [8, 18, 19] . Hence, it remains to be determined able in ventricular myocytes by in situ hybridization whether full-length, 59 truncated, or both POMC mRNAs histochemistry using an oligonucleotide probe correare expressed by cardiac tissue. sponding to the POMC gene sequence encoding b-en-
In the present study, we tested the hypothesis that dorphin's N-terminus [18] . Our laboratory subsequently POMC is synthesized by cardiomyocytes, rather than reported that POMC mRNA is also detectable in atrial cardiac neurons, by using immunohistochemistry. This myocytes by in situ hybridization [19] and McLaughlin revealed that atrial myocytes express a-MSH, b-endorphin and Wu [8] recently confirmed these findings. These data and aN-acetyl-b-endorphin immunoreactivities. Ventricular do not constitute definitive evidence that myocytes syntissue exhibited little or no immunostaining, suggesting that ventricular myocytes do not synthesize POMC, or, TBS containing 22 mg of 3,39-diaminobenzidine and 10 ml alternatively, that they synthesize and release POMC of 30% hydrogen peroxide in 100 ml of TBS. A region of rat POMC cDNA corresponding to a Rats were anesthetized with pentobarbital (60 mg / kg segment of exons 2 and 3 was amplified by using the sense i.p.) and perfused through the left ventricle with ice-cold primer sequence (LF) 59 GAG ATT CTG CTA CAG TCG phosphate-buffered saline (pH 7.4; PBS) followed by 8% CTC 39 and the antisense primer sequence (BR) 59 TTG periodate-lysine paraformaldehyde (PLP: 37.5 mM so-ATG ATG GCG TTC TTG AA 39 ( Fig. 1 ) [35] . To dium phosphate buffer, pH 7.4, containing 10 mM NaIO , amplify the 59 truncated POMC transcript, a different 4 75 mM lysine and 2% paraformaldehyde). Hearts were sense primer, BF, was used with the same antisense removed, bisected longitudinally into right and left halves, primer, BR. The BF sense primer, 59 GGC CTT TCC CCT immersed in PLP for two-three days at 48C, infiltrated AGA GTT CA 39, anneals to a sequence of POMC cDNA with 20% sucrose in PBS for 24 h and stored at 2708C.
corresponding to the ACTH coding region; hence, the Slide-mounted sections of heart tissue (15 mm) were BF / BR primers amplify both 59 truncated and full-length incubated for 12-24 h at 48C with one of several primary POMC cDNAs (Fig. 1 ). The primers were designed using antisera diluted in PBS containing 3% normal goat serum PRIMER version 0.5 software and were compared for and 0.3% Triton X-100. The primary antisera, which were known genomic sequence homology with GenBank using a generated in rabbits against rat peptide sequences, included BLAST search. a-MSH (1:300; Incstar, Stillwater, MN, USA), b-endorSingle-stranded cDNA was amplified by PCR in a phin (1:300, Incstar), aN-acetyl-b-endorphin (1:300) model PTC-100 programmable thermocycler (MJ Re- [32, 33] and ANP (1:1000, Peninsula Laboratories, Belsearch, Watertown, MA, USA) using 10 ml of the singlemont, CA, USA). After incubation with primary antiserum, stranded RT-product from cardiac tissue in 50 ml of 10 slide-mounted tissue sections were rinsed three times in mM Tris-HCl (pH 9.0) containing 50 mM KCl, 0.1% PBS containing 0.01% Triton X-100 (PBS-TX) then Triton X-100 and 10 pmol of the appropriate sense and incubated for 1 h at room temperature in goat anti-rabbit antisense primers. The samples were overlaid with mineral immunoglobulin G, diluted 1:50 in PBS-TX containing oil, heat-denatured at 958C for 5 min, and 1.6 units of Taq 3% normal goat serum, and rinsed three times in PBS-TX.
polymerase (Promega, Madison, WI, USA) were added to The sections were incubated for 1 h in rabbit peroxidaseeach sample. The samples were cycled 36 times at 958C antiperoxidase, diluted 1:100 in PBS-TX containing 1% for 1 min to denature, 658C for 1 min to anneal and at normal goat serum, then rinsed once in PBS and twice in 728C for 1 min to extend. When the amplification was 0.1 M Tris-buffered saline (pH 7.6; TBS). Finally, the finished, the samples were incubated for 10 min at 728C sections were reacted for 6-10 min with freshly prepared for final extension and were stored at 48C. PCR products (20 ml) were separated in 4% 3:1 agarose gels (Amresco, Solon, OH, USA) electrophoresed at 70 V for 1 h 15 min in 40 mM tris-acetate buffer containing 1 mM EDTA (pH 7.0). The gels were stained for 30 min in the same buffer containing 2.5 mg / ml of ethidium bromide and were then photographed.
Results
Pro-opiomelanocortin-derived peptides have been isolated from rat [12, [14] [15] [16] and human [13] heart but it is uncertain whether or not POMC is actually synthesized by cardiomyocytes. To test the hypothesis that cardiomyocytes synthesize POMC, we conducted immunohistochemical experiments using antisera against a-MSH, b-endorphin and aN-acetyl-b-endorphin. We found that atrial myocytes were immunostained by all three antisera. The immunoreactivity was granular in appearance, particularly for aN-acetyl-b-endorphin (Fig. 2B) , and was more intense in atrial appendages than in the rest of the atrium (Table 1) . Importantly, nerve fibers did not contain a-MSH, b-endorphin or aN-acetyl-b-endorphin immunoreactivity; connective tissue was similarly unstained. Atrial natriuretic peptide immunoreactivity was similarly distributed, although it was greater in intensity and more granular in appearance than POMC-peptide immunoreactivity. In control experiments, immunostaining was eliminated completely by omitting the primary antiserum ( Fig. 2A) or by preincubating each antiserum with 1 mM homologous antigen (data not shown).
In marked contrast to the atria, ventricular myocytes exhibited little or no immunoreactivity for a-MSH, aNacetyl-b-endorphin or ANP (Table 1 ). Fig. 3A shows that only faint staining was produced by the aN-acetyl-bendorphin antiserum in the left ventricle; comparable results were obtained in the right ventricle and interventricular septum (data not shown). The a-MSH and ANP antisera also produced little discernable staining in adult ventricles (Table 1) . Again, nerve fibers and connective tissue did not display a-MSH, b-endorphin, aN-acetyl-b- concentrations are found in the ventricles of neonatal rats [36] . To determine if POMC-peptide immunoreactivity is regulated similarly during development, we tested whether intensity had returned to levels that were indistinguishable or not the ventricular cardiomyocytes of rats sacrificed on from those of the adult (data not shown). Atrial natriuretic postnatal day twelve were immunostained by antisera peptide immunoreactivity was also present in ventricular against POMC peptides. Relatively intense aN-acetyl-bcardiomyocytes during the postnatal period (Table 2) as endorphin (Fig. 3B) and a-MSH (Table 2) immunostainpreviously reported [36] . ing was present, not only in the atria, but also in the To investigate further whether atrial and / or ventricular ventricles of 12-day-old rats. Comparable ventricular aNcardiomyocytes are capable of synthesizing POMC, we acetyl-b-endorphin immunostaining was observed during determined if POMC mRNA is present in rat heart. the first two postnatal weeks, but, by day 21, the staining Initially, we attempted to measure POMC mRNA by using Coronal sections from the hearts of three adult rats were immunostained with antisera against a-MSH, aN-acetyl-b-endorphin or ANP. Three sections from each heart were stained with each antiserum and the immunostaining intensity was scored as follows: 0, background staining; 0.5, minimal staining; 1.0, low staining; 1.5, moderate staining; 2.0 maximal staining (mean6SE).
Northern blot analysis. Pro-opiomelanocortin mRNA was scripts. Fig. 5 shows that a signal corresponding in size to not consistently detectable in heart extracts by Northern the predicted 215 base pair PCR product was generated by blot although it was easily measurable in the pituitary (data PCR amplification of cDNA prepared from the neurointernot shown). This means that either cardiac tissue does not mediate pituitary, ventricles, ventricular septum, atrial express the POMC gene or that POMC mRNA conappendages and atria using the BF and BR primers. The centrations are below the detection limit of Northern blot 215 base pair band was present following amplification of analysis.
cDNA from heart regions, including the atria and ventricuTo determine if small amounts of POMC mRNA are lar septum, in which the 678 base pair band was not present in rat heart, we amplified POMC mRNA using consistently detectable, which suggests that the 215 base RT-PCR [23] . For the initial experiments, RNA was pair signal is derived primarily from the short POMC extracted from the ventricle, ventricular septum, atrial transcript. Omission of either RNA or reverse transcriptase appendage, atria and pituitary neurointermediate lobe. The eliminated the signal, again indicating that it was not RNA was reverse transcribed and POMC cDNA was attributable to genomic DNA or cDNA contamination. amplified using a sense primer (LF) corresponding to part These data suggest that both full-length and 59 truncated of the POMC signal sequence encoded by exon 2 and an POMC transcripts are present in cardiac tissue. antisense primer (BR) corresponding to part of the bendorphin coding sequence in exon 3 (Fig. 1) . These primers do not amplify the 59 truncated POMC transcript, 4. Discussion which lacks exons 1 and 2 [29] .
Reverse transcription PCR amplification of RNA exPro-opiomelanocortin-derived peptides have been detracted from the left or right ventricle or atrial appendages tected in heart extracts, but their cellular location has not generated an ethidium-bromide-stained band on agarose been determined conclusively [12] [13] [14] [15] [16] [17] . In this study, we gels corresponding in size to the predicted 678 base pair tested whether or not POMC peptides are located in POMC PCR product (Fig. 4) . A 678-base-pair band was cardiomyocytes by using immunohistochemistry. We found not consistently detected by RT-PCR amplification of that a-MSH, b-endorphin and aN-acetyl-b-endorphin im-RNA extracted from the atria or ventricular septum (Fig. munoreactivities are present in atrial cardiomyocytes of 4), but repeated RT-PCR analysis of these tissues occaadult rats, particularly in the atrial appendages, but not to a sionally generated faint bands corresponding to the 678 significant extent in ventricular cardiomyocytes. Nonethebase pair PCR product (data not shown). As expected, a less, RT-PCR amplification revealed that full-length PCR product of comparable size was also amplified from POMC mRNA is present in both atria and ventricles. This pituitary neurointermediate lobe cDNA. In control experifinding is consistent with evidence that ventricular ments, omission of cardiac RNA (Fig. 4, lane C) or reverse myocytes lack secretory vesicles and secrete ANP and transcriptase (data not shown) abolished the 678 base pair other peptides by using the constitutive secretory pathway band completely, which indicates that neither genomic [3, 4, 6] . Although virtually undetectable in the ventricles of DNA nor cDNA contamination accounts for the 678 base adult rat heart, POMC-peptide immunoreactivity was pair signal. These data suggest that cardiac tissue expresses readily detectable in neonatal ventricles (Fig. 3A) and in full-length POMC mRNA.
neonatal ventricular myocyte cultures [19] , indicating that Subsequently, we determined if the 59 truncated POMC POMC peptide synthesis and / or storage is regulated transcript is expressed in cardiac tissue by using a sense during cardiac development, as reported previously for primer (BF) that anneals to a cDNA sequence corre-ANP [36] . These results support the hypothesis that sponding to the ACTH coding region of POMC mRNA.
cardiomyocytes synthesize and post-translationally process This, and the same antisense primer (BR) used previously, POMC. amplifies both 59 truncated and full-length POMC tranPro-opiomelanocortin-derived peptides and mRNA tran-found to lack the 59 region of full-length POMC mRNA corresponding to exon 2 of the POMC gene. Because exon 2 encodes the POMC signal sequence, the 800 nucleotide transcript is unlikely to undergo appropriate translation, processing and secretion [27] [28] [29] . Subsequent analyses of POMC mRNAs using more sensitive analytical methods revealed that full-length POMC mRNA is present in nonneural tissues in amounts that correspond to tissue POMCpeptide concentrations [26] . The function of the 800 nucleotide transcript, if any, is not known. Here, we report evidence that both full-length and 59 truncated POMC mRNAs are present in rat heart. By using appropriate primers, we amplified a 678-base-pair segment of full-length POMC mRNA corresponding to a portion of exons 2 and 3 of the POMC gene and a 215-base-pair segment of the ACTH / b-lipotropin coding region common to both 59 truncated and full-length POMC mRNAs. A relatively intense 678 base pair band was generated by PCR amplification of cDNA prepared from the atrial appendages but the signal was weak and inconsistently amplified from cDNA from the rest of the atria, consistent with immunohistochemical data (Table 1) . Reverse transcription PCR generated a robust 215 base pair signal from all of the heart regions that we analyzed, including the atria and ventricular septum, which evidently express little or no full-length POMC mRNA. These data indicate that both full-length and 59 truncated POMC transcripts are expressed in heart, although it is not possible to draw definitive conclusions about their relative concentrations from RT-PCR data alone.
Cardiomyocytes also synthesize proenkephalin [5] [6] [7] [8] and prodynorphin [9] [10] [11] . In contrast to ANP, proenkephalin [5] and prodynorphin [9] mRNA levels are considerably higher in ventricles than in atria, even in the adult. Indeed, proenkephalin mRNA concentrations are unusually high in the ventricles, being higher than in the hypothalamus or any other tissue [5] . Nevertheless, ventricular met-enkephalin [5] and dynorphin B [9] concentrations are quite low, again consistent with evidence that ventricular cardiomyocytes secrete peptides constitutively [3, 6] . different effects on autonomic transmission, for example. Caffrey et al. [37] reported that intra-arterial met-enscripts have also been detected in the ovary, testes and kephalin or met-enkephalin-Arg-Phe administration inseveral other non-neural tissues [21, [24] [25] [26] [27] 30, 31] . Initial hibits vagal bradycardia in dogs, apparently by activating investigations of POMC mRNA in these tissues were presynaptic delta receptors that inhibit acetylcholine redifficult to interpret because the transcript detected was lease, but does not affect the sympathetic component of smaller in size than the 1200 nucleotide POMC mRNA vagal nerve stimulation [37] . By contrast, norepinephrine isolated from the pituitary and brain, and was greater in release from sympathetic neurons is inhibited by abundance than predicted from the relatively low POMCdynorphin , a kappa receptor agonist, but apparently not 1 -9 peptide concentrations found in most non-neural tissues by met-enkephalin [38] . These data are consistent with the [26] . This smaller, 800 nucleotide transcript was later hypothesis that presynaptic delta receptors inhibit acetyl- a Coronal sections from the hearts of three 12-day-old rats were immunostained with antisera against a-MSH, aN-acetyl-b-endorphin or ANP. Three sections from each heart were stained with each antiserum and the immunostaining intensity was scored as follows: 0, background staining; 0.5, minimal staining; 1.0, low staining; 1.5, moderate staining; 2.0 maximal staining (mean6SE).
choline release from parasympathetic neurons, whereas lar myocytes and reduces the amplitude of spontaneous kappa receptors inhibit norepinephrine release from symcontractions in unstimulated cells [43] . Kappa receptor pathetic nerves innervating the heart [37] .
agonists produce the opposite response in unstimulated Delta and kappa receptor agonists also produce direct cardiomyocytes, i.e., they increase myocyte contraction effects on cardiomyocytes. Delta receptor agonists reduce and calcium influx [43, 44, 45] , although they lower calcium heart rate, cardiac output and stroke volume in isolated influx in electrically stimulated myocytes [42, 44] . Mu heart preparations [39] and lower the maximum chronotreceptor agonists have little effect on cardiomyocytes [42] ropic response to norepinephrine in isolated atria [40] .
or isolated heart preparations [39] , consistent with data Delta receptor activation also inhibits norepinephrine- [41] from receptor binding experiments showing that heart and electrically stimulated [42] calcium influx in ventricutissue contains delta and kappa, but not mu, receptors [46] . Fig. 4 . Detection of POMC mRNA in adult rat heart by RT-PCR. cDNA was prepared from 2 mg of total RNA and amplified using primers LF and BR. These primers generate a 678-base pair PCR product corresponding to a portion of exons 2 and 3 of the POMC gene (Fig. 1) . Primers LF and BR do not amplify the 59 truncated POMC transcript. NIL5neurointermediate lobe. Evidence that a 59 truncated POMC transcript is present in rat heart. cDNA was amplified using primers BF and BR, which generate a 215-base-pair product from exon 3 of both 59 truncated and full-length POMC cDNAs (Fig. 1) . NIL5neurointermediate lobe.
b-Endorphin is unlikely to participate in the opioid normal or pathogenic regulation of myocyte function regulation of cardiac function because the b-endorphin remains to be definitively elucidated. Cardiac a-MSH and peptides localized in the heart are essentially inactive as b-endorphin concentrations are relatively low (1-10 fmol / opioid receptor agonists [16] . b-Endorphin , the opioid mg protein) [14, 16] , which are 10% or less of whole brain 1 -31 form of the peptide, is almost entirely converted to bconcentrations. Low tissue concentrations are not unexendorphin , b-endorphin and their aN-acetylated pected for constitutively released peptides, but they gener-1 -27 1 -26 congeners [16] , which display little or no affinity for ally denote a paracrine or autocrine function, rather than opioid receptors [47] . The function of the non-opioid the endocrine role attributed to ANP [1, 2, 4] . The observab-endorphin peptides produced in the heart is unknown, tion that ventricular a-MSH and b-endorphin immunoalthough one b-endorphin derivative, glycyl-L-glutamine reactivities are regulated postnatally raises the possibility [b-endorphin ], has been shown to influence myocyte that POMC-peptides may play a role in heart development. 30 -31 biochemistry. Glycyl-L-glutamine induces expression of In addition, we found, in preliminary studies, that ventricuthe asymmetric forms of acetylcholinesterase in neonatal lar a-MSH immunoreactivity was elevated during cardiac ventricular myocytes [48] , a response also observed in hypertrophy, produced by constricting the abdominal aorta sympathetic ganglia [49] and chick myotubes [50] . Other of rats [19] . Atrial natriuretic peptide immunoreactivity POMC-derived peptides, including ACTH-and a-MSHwas also increased [19] , consistent with reports that cardiac related peptides, also influence cardiac function; they hypertrophy induces proANF gene expression [2] . Cardiac enhance sympathetic transmission in rat atria [51] [52] [53] , hypertrophy also induces ventricular proenkephalin [56, 57] increase heart rate in isolated guinea pig heart preparations and prodynorphin [58] gene expression, which suggests [54] and are potent pressor and cardioaccelerator agents that all three opioid peptide families may be involved in when injected intravenously [55] . Hence, the major careither the pathogenesis or the compensatory response to dioactive products of POMC processing in the heart may cardiac hypertrophy. be melanocortin, rather than opioid peptides.
In summary, these data show that immunoreactive aNevertheless, the exact role of POMC-peptides in the MSH, b-endorphin and aN-acetyl-b-endorphin are present
